Riskpilot← Back to searchSign inGet full accessExorbio AB
ABActiveOrg 5591393110Aschebergsgatan 17 Lgh 1402Activities of holding companies · NACE 6421Est. 20170 employees
Revenue 2024
SEK 0
EBITDA margin
—
-45% vs 2023
Equity ratio
99.1%
Financial strength
Net profit 2024
SEK 1,8M
+269% vs 2023
| Revenue | SEK 0 | — |
| EBITDA | SEK -286K | -45% |
| Net profit | SEK 1,8M | +269% |
| Total assets | SEK 32,1M | +7% |
| Equity | SEK 31,9M | +6% |
| Employees | 0 | — |
Legal name
Exorbio AB
Org number
5591393110
Legal form
Aktiebolag
NACE code
6421 · Activities of holding companies
Founded
13 december 2017
Share capital
SEK 60 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget skall äga och förvalta aktier samt bedriva därmed förenlig verksamhet.
Address
Aschebergsgatan 17 Lgh 1402
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | — | — | — | — | — | — | — |
| EBITDA | −29 | −99 | −291 | −232 | −302 | −197 | −286 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 | −0 | — |
| EBIT | −29 | −99 | −291 | −232 | −302 | −197 | −286 |
| Net financials | 30 064 | −112 | −1 760 | 2 100 | −798 | 761 | 2 528 |
| Profit before tax | 30 034 | −211 | −1 266 | 1 869 | −645 | 564 | 2 242 |
| Tax | −0 | −0 | −0 | −280 | −0 | −75 | −439 |
| Net profit | 30 034 | −211 | −1 266 | 1 589 | −645 | 489 | 1 803 |
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Total assets | 30 116 | 29 922 | 28 788 | 30 544 | 29 895 | 30 182 | 32 145 |
| Equity | 30 094 | 29 883 | 28 617 | 30 206 | 29 561 | 30 050 | 31 853 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | — |
| Short-term debt | 22 | 39 | 171 | 338 | 334 | 131 | 292 |
| Total debt | 22 | 39 | 171 | 338 | 334 | 131 | 292 |
EBITDA margin
-28571400.0%
This company
15.8%
Market median
-180831746% vs market
20182024
Equity ratio
99.1%
This company
38.2%
Market median
+159% vs market
20182024
Return on equity
5.7%
This company
18.4%
Market median
-69% vs market
20182024
Net profit margin
180309300.0%
This company
8.1%
Market median
+2226040641% vs market
20182024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20182024
Debt / equity
0.01×
This company
0.62×
Market median
+98% vs market
20182024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2017-12-01 – 2018-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
PM Audit | Audit | 2022 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Deputy Board Member | 2020 | — | — | |
| Board of Directors | 2020 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Exorbio AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Per Markus Hellsten | Audit | 0 companies |
| Helene Sophie Petersson Hurtigh | Deputy Board Member | 0 companies |
| Per-Anders Eugén Hurtigh | Board of Directors | 0 companies |